Diarrhea Predominant Irritable Bowel Syndrome
Conditions
Brief summary
The investigators will evaluate the efficacy of multi-strain probiotics in adults with diarrhea predominant irritable bowel syndrome.
Interventions
* B. longum BORI: 1 x 109 * B. bifidum BGN4: 1 x 109 * B. lactis AD011: 1 x 109 * B. infantis IBS007: 1 x 109 * Lactobacillus acidophilus AD031: 1 x 109 three times a day, within 10 minutes after meal, per oral with water
same taste, shape, dosage as experimental drug three times a day, within 10 minutes after meal, per oral with water
Sponsors
Study design
Eligibility
Inclusion criteria
* willing to consent/undergo necessary procedures * between the age of 19 and 75 years * diarrhea predominant irritable bowel syndrome (satisfied with Rome II criteria)
Exclusion criteria
* uncontrolled hypertension (Blood pressure \> 180/110 mmHg) * uncontrolled diabetes mellitus (FBS \> 200 mg/dL) * malignancy, cerebrovascular disease, cardiovascular disease * history of abdominal surgery except appendectomy and hernia repair * inflammatory bowel disease * clinically or laboratory-confirmed gastroenteritis * the use of motility drug or dietary fiber supplement in 2 weeks * serum Cr \> 2 x Upper normal limit * AST or ALT \> 2 x Upper normal limit * Pregnancy, Lactating woman
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change of Irritable bowel syndrome symptom severity score (IBS-SSS) | after 8 weeks | Severity and frequency of abdominal pain / abdominal bloating / bowel habitus / interfere degree of daily life |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assessment for patient satisfaction after administration completion | after 4 weeks and 8 weeks | — |
| Stool frequency and form | after 4 weeks and 8 weeks | Stool frequency (greater than 3 bowel movements/day or less than 3 bowel movements/week) Stool form (lumpy / hard or loose / watery stool) |
| Symptom control of irritable bowel syndrome | after 4 weeks and 8 weeks | — |
| Improvement of overall symptom in patient with irritable bowel syndrome | after 4 weeks and 8 weeks | — |
| Assessment for quality of life related with irritable bowel syndrome | after 4 weeks and 8 weeks | — |
Countries
South Korea